Correction: Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis

There are errors in the author affiliations. The correct affiliations are as follows:

Torsten Diesinger^{1, 2, 3}*, Vyacheslav Buko^4,5, Alfred Lautwein¹, Radovan Dvorsky^6,7, Elena Belonovskaya⁴, Oksana Lukivskaya⁴, Elena Naruta⁴, Siarhei Kirko⁴, Viktor Andreev⁸, Dominik Buckert^1,9, Sebastian Bergler¹, Christian Renz¹, Edith Schneider¹⁰, Florian Kuchenbauer^10,11, Mukesh Kumar¹², Cagatay Günes¹², Berthold Büchele¹³, Thomas Simmet¹³, Dieter Müller-Enoch¹, Thomas Wirth¹, Thomas Haehner¹

1 Institute of Physiological Chemistry, Ulm University, Ulm, Germany, 2 Department of Internal Medicine, Neu-Ulm Hospital, Neu-Ulm, Germany, 3 Chair of Biochemistry and Molecular Medicine, Witten/Herdecke University, Witten, Germany, 4 Division of Biochemical Pharmacology, Institute of Biochemistry of Biologically Active Substances, Grodno, Belarus, 5 Department of Biotechnology, University of Medical Sciences, Bialystok, Poland, 6 Institute of Biochemistry and Molecular Biology II, Medizinische Fakultät der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany, 7 Max Planck Institute of Molecular Physiology, Dortmund, Germany, 8 Department of Medical Biology and Genetics, Grodno State Medical University, Grodno, Belarus, 9 Department of Internal Medicine II, University Hospital Ulm, Ulm, Germany, 10 Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany, 11 University of British Columbia, Terry Fox Laboratory, Vancouver, Canada, 12 Department of Urology, University Hospital Ulm, Ulm, Germany, 13 Institute of Pharmacology of Natural Products and Clinical Pharmacology, University Ulm, Ulm, Germany

The publisher apologizes for the error.